MA28662B1 - 1-BETA-HYDROXY STEROID DEHYDROGENASE INHIBITORS OF TYPE 1 - Google Patents

1-BETA-HYDROXY STEROID DEHYDROGENASE INHIBITORS OF TYPE 1

Info

Publication number
MA28662B1
MA28662B1 MA29529A MA29529A MA28662B1 MA 28662 B1 MA28662 B1 MA 28662B1 MA 29529 A MA29529 A MA 29529A MA 29529 A MA29529 A MA 29529A MA 28662 B1 MA28662 B1 MA 28662B1
Authority
MA
Morocco
Prior art keywords
beta
type
dehydrogenase inhibitors
steroid dehydrogenase
hydroxy steroid
Prior art date
Application number
MA29529A
Other languages
French (fr)
Inventor
Martin Henriksson
Evert Homan
Lars Johansson
Jerk Vallgarda
Meredith Williams
Eric Bercot
Christopher H Fotsch
Aiwen Li
Guolin Cai
Randall W Hungate
Chester Chenguang Yuan
Chirstopher Tegley
Jean David St
Nianhe Han
Qi Huang
Qingyian Liu
Michael D Bartberger
George A Moniz
Matthew J Frizzle
Original Assignee
Amgen Inc
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0401324A external-priority patent/SE0401324D0/en
Priority claimed from SE0402509A external-priority patent/SE0402509D0/en
Application filed by Amgen Inc, Biovitrum Ab filed Critical Amgen Inc
Publication of MA28662B1 publication Critical patent/MA28662B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention se rapporte à des composés de la formule (I), (II), (III) ou (IV) : où R1, R2, R3, R4, R5, R6, R7, X et Z sont tel que définis dans les présentes, comme elle se rapporte également aux compositions pharmaceutiques comportant les composés, aussi bien que les méthodes d'utilisation des composés pour le traitement des troubles associés à l'enzyme de déshydrogénase humaine 11-(beta)-hydroxysteroïde de type 1 et pour la préparation d'un médicament qui agit sur l'enzyme de déshydrogénase humaine 11-(beta)-hydroxysteroïde de type 1.The present invention relates to compounds of the formula (I), (II), (III) or (IV): wherein R1, R2, R3, R4, R5, R6, R7, X and Z are as defined in herein, as well as the pharmaceutical compositions comprising the compounds, as well as the methods of using the compounds for the treatment of disorders associated with the human 1-(beta) -hydroxysteroid dehydrogenase enzyme type 1 and for the preparation of a drug which acts on the human dehydrogenase enzyme 11- (beta) -hydroxysteroid type 1.

MA29529A 2004-05-24 2006-12-14 1-BETA-HYDROXY STEROID DEHYDROGENASE INHIBITORS OF TYPE 1 MA28662B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0401324A SE0401324D0 (en) 2004-05-24 2004-05-24 New compounds
SE0402509A SE0402509D0 (en) 2004-10-15 2004-10-15 New compounds
US65077705P 2005-01-31 2005-01-31

Publications (1)

Publication Number Publication Date
MA28662B1 true MA28662B1 (en) 2007-06-01

Family

ID=41717469

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29529A MA28662B1 (en) 2004-05-24 2006-12-14 1-BETA-HYDROXY STEROID DEHYDROGENASE INHIBITORS OF TYPE 1

Country Status (10)

Country Link
KR (1) KR101296408B1 (en)
CR (2) CR8771A (en)
EC (1) ECSP067108A (en)
HK (1) HK1096095A1 (en)
HR (1) HRP20060456A2 (en)
IL (1) IL179167A (en)
MA (1) MA28662B1 (en)
MX (1) MXPA06013657A (en)
NO (1) NO20065781L (en)
NZ (1) NZ552284A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228111B1 (en) 1998-07-08 2012-11-28 Sanofi Aventis Deutschland Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them

Also Published As

Publication number Publication date
HRP20060456A2 (en) 2007-03-31
IL179167A0 (en) 2007-03-08
HK1096095A1 (en) 2007-05-25
CR20120420A (en) 2012-09-14
CR8771A (en) 2007-07-24
KR20070058382A (en) 2007-06-08
IL179167A (en) 2012-01-31
MXPA06013657A (en) 2007-11-07
NZ552284A (en) 2010-01-29
ECSP067108A (en) 2007-05-30
NO20065781L (en) 2007-02-08
KR101296408B1 (en) 2013-08-13

Similar Documents

Publication Publication Date Title
MA28469B1 (en) INHIBITORS OF DIPEPTIDYL PEPTIDASE
MA28746B1 (en) Quinazolin-4-yl-piperidine and cinnolin-4-yl-piperidine derivatives as PDE10 inhibitors for the treatment of CNS disorders
MA30333B1 (en) AMINOTETRAHYDROPYRANES USEFUL AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV FOR THE TREATMENT OR PREVENTION OF DIABETES.
MXPA02011632A (en) Inhibitors of 11 beta hydroxy steroid dehydrogenase type 1.
MA27647A1 (en) CCR5 ANTAGONISTS USEFUL AS THERAPEUTIC AGENTS
TN2010000230A1 (en) NEW AGONISTS OF GLUCOCORTICOID RECEPTORS
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MA28466B1 (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE IN THE TREATMENT OF METABOLIC DISORDERS
MA33053B1 (en) INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE (PARP)
NO20042596L (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MA26727A1 (en) NOVEL PYRIMIDINE DERIVATIVES OF SORBITOL DEHYDROGENASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA27174A1 (en) NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS.
MXPA04004842A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
MXPA04004837A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
MA30421B1 (en) PIPERIDINYL-SUBSTITUTED PYRROLIDINONES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1
MA31521B1 (en) Derivatives 3,2-dihydropenzo [1,4] dioxin-2-yl methyl are used as alpha2c antagonists for the treatment of diseases of the central and peripheral nervous system.
MA29387B1 (en) INHIBITORS OF DIPEPTIDYL PEPTIDASE IV
MA33219B1 (en) SUBSTITUTED AZOANTHRACENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
MA26946A1 (en) NEW PYRAZOLE DERIVATIVES AND THEIR USE AS PROTEIN-KINASE INHIBITORS.
TNSN05073A1 (en) NOVEL SPIROCONDENSE QUINAZOLINONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
MA27692A1 (en) COMPOUNDS DERIVED FROM BENZOXAZINONE, THEIR PREPARATION AND USE AS MEDICAMENTS
TNSN06358A1 (en) SUBSTITUTED METHYL-ARYL-OR-HETEROARYL-AMIDES
MA30602B1 (en) MODULATORS OF METABOLISM AND TREATMENT OF DISORDERS USING THESE MODULATORS
MA30412B1 (en) Pharmaceutical Compounds
MA32627B1 (en) HETEROARYLIC AMIDE DERIVATIVE AND THEIR USE AS GLUCOKINASE ACTIVATORS